471 related articles for article (PubMed ID: 30921182)
1. The clinical significance of microRNA-122 in predicting the prognosis of patients with hepatocellular carcinoma: A meta-analysis validated by the Cancer Genome Atlas dataset.
Zhang Y; Li Y; Jiang W; Li Q; Lan Y
Medicine (Baltimore); 2019 Mar; 98(13):e14810. PubMed ID: 30921182
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Value and Regulatory Mechanisms of microRNA-145 in Various Tumors: A Systematic Review and Meta-analysis of 50 Studies.
Xu L; Zhang Y; Tang J; Wang P; Li L; Yan X; Zheng X; Ren S; Zhang M; Xu M
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):867-881. PubMed ID: 30602498
[TBL] [Abstract][Full Text] [Related]
3. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis of clinical significance and functional involvement of microRNAs in hepatocellular carcinoma.
Qin L; Huang J; Wang G; Huang J; Wu X; Li J; Yi W; Qin F; Huang D
J Cell Physiol; 2019 Dec; 234(12):23581-23595. PubMed ID: 31210353
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
6. Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection.
Song SK; Jung WY; Park SK; Chung CW; Park Y
PLoS One; 2019; 14(9):e0216847. PubMed ID: 31513595
[TBL] [Abstract][Full Text] [Related]
7. The Prognostic Significance of miR-21 Expression among Surgically Resected Hepatocellular Carcinoma Patients: Evidence from a Meta-Analysis and Retrospective Cohort Study.
Huang X; Xiong Y; Yang J; Yang G; Li J
Biomed Res Int; 2020; 2020():8848158. PubMed ID: 33415165
[TBL] [Abstract][Full Text] [Related]
8. High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
Diagn Pathol; 2014 Aug; 9():160. PubMed ID: 25123453
[TBL] [Abstract][Full Text] [Related]
9. Prognostic values of microRNA-130 family expression in patients with cancer: a meta-analysis and database test.
Peng Z; Duan F; Yin J; Feng Y; Yang Z; Shang J
J Transl Med; 2019 Oct; 17(1):347. PubMed ID: 31640738
[TBL] [Abstract][Full Text] [Related]
10. Low microRNA-139 expression associates with poor prognosis in patients with tumors: A meta-analysis.
Chen JA; Yu Y; Xue C; Chen XL; Cui GY; Li J; Li KF; Ren ZG; Sun RR
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):321-331. PubMed ID: 30290990
[TBL] [Abstract][Full Text] [Related]
11. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
12. Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma.
Köberle V; Kronenberger B; Pleli T; Trojan J; Imelmann E; Peveling-Oberhag J; Welker MW; Elhendawy M; Zeuzem S; Piiper A; Waidmann O
Eur J Cancer; 2013 Nov; 49(16):3442-9. PubMed ID: 23810247
[TBL] [Abstract][Full Text] [Related]
13. Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment.
Cho HJ; Kim SS; Nam JS; Kim JK; Lee JH; Kim B; Wang HJ; Kim BW; Lee JD; Kang DY; Kim JH; Jae YM; Hwang JC; Shin SJ; Lee KM; Cho SW; Cheong JY
Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):181-189. PubMed ID: 27839726
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-200c expression is decreased in hepatocellular carcinoma and associated with poor prognosis.
Luo C; Pu J; Liu F; Long X; Wang C; Wei H; Tang Q
Clin Res Hepatol Gastroenterol; 2019 Nov; 43(6):715-721. PubMed ID: 30962170
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of miR-21 in gliomas: comprehensive study based on meta-analysis and TCGA dataset validation.
Jiang G; Mu J; Liu X; Peng X; Zhong F; Yuan W; Deng F; Peng X; Peng S; Zeng X
Sci Rep; 2020 Mar; 10(1):4220. PubMed ID: 32144351
[TBL] [Abstract][Full Text] [Related]
16. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
17. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
[TBL] [Abstract][Full Text] [Related]
19. A P53-related microRNA model for predicting the prognosis of hepatocellular carcinoma patients.
Fang SS; Guo JC; Zhang JH; Liu JN; Hong S; Yu B; Gao Y; Hu SP; Liu HZ; Sun L; Zhao Y
J Cell Physiol; 2020 Apr; 235(4):3569-3578. PubMed ID: 31556110
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the Prognostic Value of microRNA-203 in Solid Tumors Based on a Meta-Analysis and the Cancer Genome Atlas (TCGA) Datasets.
Shao Y; Gu W; Ning Z; Song X; Pei H; Jiang J
Cell Physiol Biochem; 2017; 41(4):1468-1480. PubMed ID: 28351024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]